Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02227446
PHASE3

Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (VANCO)

Sponsor: Major Extremity Trauma Research Consortium

View on ClinicalTrials.gov

Summary

The Vancomycin Study is a multi-center, prospective randomized controlled trial that will compare the proportion of deep surgical site infections within 6 months in patients treated with local Vancomycin powder compared to those treated without local Vancomycin powder at the time of fracture fixation.

Official title: Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (Vancomycin Study)

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

1036

Start Date

2014-10

Completion Date

2019-11

Last Updated

2026-07-06

Healthy Volunteers

No

Interventions

DRUG

Vancomycin antibiotic powder

At the time of fracture fixation 1000 mg of Vancomycin powder placed into the wound during wound closure.

Locations (1)

University of Maryland R Adams Cowley Shock Trauma Center

Baltimore, Maryland, United States